Suppr超能文献

尿路结石与尿路感染。一项临床与微生物学研究。

Urinary calculi and urinary tract infection. A clinical and microbiological study.

作者信息

Holmgren K

出版信息

Scand J Urol Nephrol Suppl. 1986;98:1-71.

PMID:3026032
Abstract

The problem of urinary calculi in association with urinary tract infection (UTI) was investigated. Fifty-two (7%) of 796 patients attending our outpatient stone clinic had UTI which was considered of pathogenic importance for their stone formation. Proteus was the most common microorganism. Metabolic disorders were found in one third and anatomical and functional abnormalities in two thirds of the patients. The infected patients had lower urinary calcium excretion and higher serum creatinine than idiopathic stone formers and had a higher frequency of stone operations. The prevalence of staghorn calculi as a cause of urimia was low (1.5% of 481 dialysis patients). Eight such patients were studied and six of them had metabolic and anatomical disorders. The time taken for the uremia to develop was 7.4 +/- 2.0 (SD) years. In 535 patients treated surgically for renal calculi, about one third had positive urine culture at the time of operation and E. coli was the most common bacterial strain (35%). Proteus was found in 28% and these patients had the highest frequency of UTI episodes, most of which occurred before hospitalization. Patients infected with E. coli had a higher frequency of phosphate-containing calculi than non-infected patients, in whom the highest frequency of calcium oxalate calculi was found. A new broad-spectrum cephalosporin, ceftazidime, was used as perioperative prophylaxis in 15 patients operated upon for renal calculi and UTI. Ten had bacterial growth in the renal pelvis and all strains were eradicated. Bacterial growth was found in two out of six cultured stones from patients with bacterial growth in the pelvis. The pharmacokinetics of the drug was studied and the decreases in the ceftazidime levels in serum and renal tissue seemed to be parallel. Bacterial binding of urinary isolates to hydroxyapatite (HAP) particles was studied. Two E. coli strains (A5089 and E7704) and one Proteus mirabilis strain (A5076), all obtained from stone patients, were compared with two E. coli strains (2683 and M7810) with well defined cell-surface properties. Hemagglutination tests were performed and the cell-surface hydrophobicity was determined by a salt-aggregating test. When the strains were cultured at 37 degrees C to promote fimbriae formation they hemagglutinated erythrocytes and displayed hydrophobic cell-surface properties, and showed higher capacity for binding to HAP than when cultured at 18 degrees C to suppress fimbriae formation, when they showed almost complete absence of hemagglutination and low cell-surface hydrophobicity. Bacterial cell-surface properties seem to influence the binding of uropathogens to HAP particles.

摘要

对尿路结石合并尿路感染(UTI)的问题进行了研究。在我们门诊结石诊所就诊的796例患者中,有52例(7%)发生了UTI,这被认为对其结石形成具有致病重要性。变形杆菌是最常见的微生物。三分之一的患者存在代谢紊乱,三分之二的患者存在解剖和功能异常。与特发性结石形成者相比,感染患者的尿钙排泄较低,血清肌酐较高,且结石手术频率较高。鹿角形结石作为尿毒症病因的患病率较低(481例透析患者中的1.5%)。对8例此类患者进行了研究,其中6例存在代谢和解剖紊乱。尿毒症发展所需时间为7.4±2.0(标准差)年。在535例接受肾结石手术治疗的患者中,约三分之一在手术时尿培养呈阳性,大肠杆菌是最常见的菌株(35%)。变形杆菌在28%的患者中被发现,这些患者的UTI发作频率最高,其中大多数发生在住院前。感染大肠杆菌的患者含磷酸盐结石的频率高于未感染患者,未感染患者中草酸钙结石的频率最高。一种新的广谱头孢菌素头孢他啶被用作15例接受肾结石和UTI手术患者的围手术期预防用药。10例肾盂有细菌生长,所有菌株均被清除。在肾盂有细菌生长的患者的6块培养结石中,有2块发现有细菌生长。对该药物进行了药代动力学研究,血清和肾组织中头孢他啶水平的下降似乎是平行的。研究了尿液分离株与羟基磷灰石(HAP)颗粒的细菌结合情况。将从结石患者中分离得到的2株大肠杆菌(A5089和E7704)和1株奇异变形杆菌(A5076)与2株具有明确细胞表面特性的大肠杆菌(2683和M7810)进行了比较。进行了血凝试验,并通过盐聚集试验测定了细胞表面疏水性。当菌株在37℃培养以促进菌毛形成时,它们会凝集红细胞并表现出疏水性细胞表面特性,并且与在18℃培养以抑制菌毛形成时相比,显示出更高的与HAP结合能力,此时它们几乎完全没有血凝现象且细胞表面疏水性较低。细菌细胞表面特性似乎会影响尿路病原体与HAP颗粒的结合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验